Anthony Barnett - Articles and news items

Boehringer Ingelheim logo
Boehringer Ingelheim logo

Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe

Industry news, News / 25 August 2011 / Boehringer Ingelheim

Marketing Authorisation from the European Commission for Trajenta® (linagliptin)…

Boehringer Ingelheim logo

Linagliptin recommended for approval in the treatment of type 2 diabetes

Industry news, News / 24 June 2011 / Boehringer Ingelheim

Boehringer Ingelheim and Eli Lilly received a positive opinion from the EMA’s medicinal committee…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+